Ask Michael Burke Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Exacctnt who wrote (28668)	5/31/1998 2:03:00 PM
From: Knighty Tin	Read Replies (1) of 132070

Bob, Life Sciences and drugs are not stand alone products. Many times things that are beneficial for plant life or yield or size is also beneficial for humans. So, I see lots and lots of partnerships in this area. I doubt that many drug cos will follow the Novartis lead and buy out small agri-biotech and life sciences cos., if for no other reason than that those cos. may not one to lock into one distributor. I believe it will be more of a product by product situation. Despite the recent takeovers, many drug cos. have learned that you cannot buy creativity, as their biotech folks seem to lose their edge after a merger. I could be wrong, but I like for more cooperative arrangements, and fewer outright takeovers. However, I expect the good life sciences cos., even some smaller ones, to benefit strongly from this trend. MB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next